Bright Minds Biosciences (DRUG) Institutional Ownership $39.75 +0.93 (+2.40%) (As of 12/17/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Bright Minds Biosciences (NASDAQ:DRUG)CurrentInstitutional OwnershipPercentage40.52%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$28.87KNumber ofInstitutional Sellers(last 12 months)0 Get DRUG Insider Trade Alerts Want to know when executives and insiders are buying or selling Bright Minds Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data DRUG Institutional Buying and Selling by Quarter Ad Crypto 101 MediaThis Crypto Is Set to Explode in DecemberDiscover our #1 crypto for the Trump Presidency Bull Run now! (Available for a Short Time) We highly recommend this hot altcoin before prices get too high Check it out by going here now Bright Minds Biosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/14/2024 AdvisorShares Investments LLC188,119$273K0.1%+12.0%4.246% 11/6/2023 AdvisorShares Investments LLC167,930$267K0.1%-67.4%4.452% 8/9/2023 AdvisorShares Investments LLC515,315$294K0.1%+14.7%14.640% 5/9/2023 AdvisorShares Investments LLC449,155$198K0.1%+42.7%2.553% 8/8/2022 AdvisorShares Investments LLC289,576$237K0.1%+40.1%2.439% 5/9/2022 AdvisorShares Investments LLC206,716$314K0.1%+115.5%1.745% 2/9/2022 Checchi Capital Advisers LLC14,138$45K0.0%N/A0.119% 1/31/2022 AdvisorShares Investments LLC95,942$304K0.0%N/A0.810% (Data available from 1/1/2016 forward) DRUG Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of DRUG shares? During the previous two years, the following institutional investors and hedge funds held shares of Bright Minds Biosciences shares: AdvisorShares Investments LLC ($273K).Learn more on DRUG's institutional investors. What percentage of Bright Minds Biosciences stock is owned by institutional investors? 40.52% of Bright Minds Biosciences stock is owned by institutional investors. Learn more on DRUG's institutional investor holdings. Which institutional investors have been buying Bright Minds Biosciences stock? The following institutional investors have purchased Bright Minds Biosciences stock in the last 24 months: AdvisorShares Investments LLC ($220.64K). How much institutional buying is happening at Bright Minds Biosciences? Institutional investors have bought a total of 220,641 shares in the last 24 months. This purchase volume represents approximately $512.97K in transactions. Which Bright Minds Biosciences major shareholders have been selling company stock? The following institutional investors have sold Bright Minds Biosciences stock in the last 24 months: AdvisorShares Investments LLC ($347.39K). How much institutional selling is happening at Bright Minds Biosciences? Institutional investors have sold a total of 347,385 shares in the last 24 months. This volume of shares sold represents approximately $555.82K in transactions. Related Companies Dianthus Therapeutics Institutional Ownership Rapport Therapeutics Institutional Ownership Autolus Therapeutics Institutional Ownership Oculis Institutional Ownership Cullinan Therapeutics Institutional Ownership Prothena Institutional Ownership Entrada Therapeutics Institutional Ownership Arbutus Biopharma Institutional Ownership Tectonic Therapeutic Institutional Ownership Stoke Therapeutics Institutional Ownership This page (NASDAQ:DRUG) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bright Minds Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bright Minds Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
